Figure 6
Biochemical analysis of the brains of Tau 3R/4R mice after unilateral injection of the sarkosyl-insoluble fraction of the tauopathies or control brains into the striatum. Sarkosyl-insoluble fractions were prepared 8 months after injection and analysed by western blotting with anti-tau antibodies T46 (A), AT8 (B), pS396 (C), RD3 (D) and anti-4R tau (E). The red arrowhead in (D) indicates 3R tau and the blue arrowhead in (E) indicates 4R tau. AC = age-matched control; AD = Alzheimer’s disease; CBD = corticobasal degeneration; HD = Huntington’s disease; PiD = Pick’s disease. Molecular weight markers are shown on the left (kDa).

Biochemical analysis of the brains of Tau 3R/4R mice after unilateral injection of the sarkosyl-insoluble fraction of the tauopathies or control brains into the striatum. Sarkosyl-insoluble fractions were prepared 8 months after injection and analysed by western blotting with anti-tau antibodies T46 (A), AT8 (B), pS396 (C), RD3 (D) and anti-4R tau (E). The red arrowhead in (D) indicates 3R tau and the blue arrowhead in (E) indicates 4R tau. AC = age-matched control; AD = Alzheimer’s disease; CBD = corticobasal degeneration; HD = Huntington’s disease; PiD = Pick’s disease. Molecular weight markers are shown on the left (kDa).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close